MAP3K1 and central nervous system cancer: Researchers have reported that many genetic biomarkers, such as CAMKK2,35 GINS2,36 FOXD1‐AS1,37 CpGs methylation,38 TRIB2, and MAP3K1,39 have significant impact on the prognosis of glioma and could be used as prognosis predictors of glioma.